D’autres conférences présentées par EOCI :
2018 Agenda - Friday, May 11
7:30 a.m.
Breakfast Buffet and Registration Pre-Function Space Level 700
Joint Plenary: Precision Medicine: Patient, Population, or Both?
Co-Chairs: Jonathan Howlett, MD | Mansoor Husain, MD 718 A&B
8:30 a.m.
Welcome and introduction Jonathan Howlett, MD
8:35 a.m.
Can macrodata predict response to therapy? Larry Allen, MD
8:55 a.m.
Genes to genomes: Evolution of molecular testing for inherited cardiomyopathy Birgit Funke, PhD
9:15 a.m.
The journey of the biomarker from bench to bedside Douglas Lee, MD
9:35 a.m. Plenary Q&A
9:50 a.m.
Flash science trainee presentations  
10:00 a.m.
Break Pre-Function Space Level 700
10:25 –
11:40 a.m.
CHFS Clinical Workshops I
Ted Rogers Centre Scientific Session: How to Engineer a Heart
Chair: Craig Simmons, PhD
Choose one to attend:
Featured presentations and Q&A:
CCS comprehensive HF guidelines – Michael McDonald, MD - Eileen O'Meara, MD 716 A
Biomaterials that improve heart function – Ren-Ke Li, MD 714 A&B
Ms. Understood: Gender-based differences and HF therapies: Drugs, devices and surgery – Vivek Rao, MD - Shelley Zieroth, MD 716 B
The genomic blueprint of the heart – Benoit Bruneau, PhD 714 A&B
What patient advocacy means in 2018 – Jillianne Code, PhD - Sean Virani, MD 717 A
Importance of vasculature to heart regeneration – Sara Vasconcelos, PhD 714 A&B
11:40 a.m.
Lunch Buffet Opens Pre-Function Space Level 700
12:05 –
1:20 p.m.
Lunch Symposium: Time to treatment in HF: The time is now
Jonathan Howlett, MD (Chair) - Martin Cowie, MD - Nadia Giannetti, MD - Peter Liu, MD 718 A&B
Joint Plenary: Evolving Concepts in Heart Failure
Co-Chairs: Carolina Alba, MD | Michael Farkouh, MD 718 A&B
1:35 p.m.
Amlodipine therapy for iron-overload cardiomyopathy: The enduring value of translational research Gavin Oudit, MD
1:55 p.m.
Heart failure with and without atrial fibrillation: Are they different diseases? Martin Cowie, MD
2:15 p.m.
Update on ischemic conditioning: Bench to bedside opportunities for clinical translation Nicolas Noiseux, MD
2:35 p.m. Plenary Q&A
2:50 p.m.
Flash science trainee presentations  
3:00 p.m.
Break Pre-Function Space Level 700
3:20 –
4:35 p.m.
CHFS Clinical Workshops II
Ted Rogers Centre Scientific Session: Cardiac Signalling & Metabolism
Chair: Sara Vasconcelos , PhD
Choose one to attend:
Featured presentations and Q&A:
Bridging the gap between clinical medicine and basic science: Opening Pandora's box – Phyllis Billia, MD - Anthony Gramolini, PhD 717 A
Can modulating cardiac metabolism prevent HF? – Mansoor Husain, MD 714 A&B
Nursing: Managing goals of care - Leah Steinberg, MD - Pat Strachan, RN, PhD 716 A
HDL and cell signalling in the heart: Roles in cardioprotection - Bernardo Trigatti, PhD 714 A&B
Cardiorenal disease – Nadia Giannetti, MD 716 B
Apelin analogues as novel therapies for cardiovascular disease – Gavin Oudit, MD 714 A&B
4:35 p.m. End of Daily Program
2018 Agenda - Saturday, May 12
7:30 a.m.
Breakfast Buffet and Registration Pre-Function Space Level 700
7:55 –
8:55 a.m.
Breakfast Symposium: Questions about Diabetes and HF you were too afraid to ask
Shelley Zieroth, MD (Chair) - Vineeta Ahooja, MD - Kim Connelly, MBBS, PhD - Elizabeth Swiggum, MD - Subodh Verma, MD, PhD 718 A&B
Joint Plenary: Sweet Failure: HFpEF and Diabetes
Co-Chairs: Mansoor Husain, MD | Eileen O'Meara, MD 718 A&B
9:05 a.m.
Opening remarks Mansoor Husain, MD
9:10 a.m.
Targeting the diagnosis of HFpEF Justin Ezekowitz, MB BCh
9:25 a.m.
New and emerging heart failure therapies: 2018 and beyond John McMurray, MD
9:45 a.m.
Diabetic cardiomyopathy: Real or imagined? Kim Connelly, MBBS, PhD
10:00 a.m. Plenary Q&A
10:15 a.m.
Flash science trainee presentations  
10:25 a.m.
Break Pre-Function Space Level 700
10:45 -
12:00 p.m.
CHFS Clinical Workshops III
Ted Rogers Centre Scientific Session: The importance of genomics to our understanding of heart disease
Chair: Seema Mital, MD
Choose one to attend:
Featured presentations and Q&A:
Nursing: Initiation & titration of HF medications – Karen Harkness, RN, PhD - Serge Lepage, MD 716 A
Genomic-guided therapies: Can we cure cardiomyopathy? – Carolyn Ho, MD 714 A&B
Advanced HF therapies: When to refer patients – Stephanie Poon, MD 716 B
How deep learning can predict cardiac arrest – Anna Goldenberg, PhD 714 A&B
Imaging tools for HF in 2018 – Carolina Alba, MD - Nowell Fine, MD 717 A
A novel biomarker for arrhythmogenic cardiomyopathy – Robert Hamilton, MD 714 A&B
12:00 p.m.
Lunch Buffet Opens Pre-Function Space Level 700
12:25 –
1:40 p.m.
Lunch Symposium: Interrupting the pathway of heart failure
Jonathan Howlett, MD (Chair) - John McMurray, MD - Sean Virani, MD - Karen Harkness, RN, PhD 718 A&B
Joint Plenary: What we must know about cardiotoxicity
Co-Chairs: Serge Lepage, MD | Dinesh Thavendiranathan, MD 718 A&B
1:55 p.m.
Why cardiologists must care about cancer immunotherapy Javid Moslehi, MD
2:15 p.m.
Clonal hematopoiesis: A pathway to cancer, a pathway to heart disease Aaron Schimmer, MD
2:35 p.m.
Novel diagnosis and treatment of cardiac amyloidosis: Can we cure the incurable? Natalie Galant, PhD
2:55 p.m. Plenary Q&A
3:10 p.m.
Closing remarks Serge Lepage, MD
3:10 -
4:00 p.m.
Trainee Research Showcase & Reception 714 A&B